Overview
Anna Angona practices practicing medicine in Girona, Spain.
Ms. Angona is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Essential Thrombocythemia, Polycythemia Vera, Myeloproliferative Neoplasms (MPN), Myelofibrosis, and Vertebroplasty.
She is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 2 clinical trials.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Frequently Asked Questions about Anna Angona
Is Anna Angona a top-rated expert for Essential Thrombocythemia?
MediFind is an objective health platform that identifies experts based on real-world data. Anna Angona is classified as an Elite expert for Essential Thrombocythemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anna Angona participate in research or clinical trials?
Yes. Anna Angona has published 57 articles and abstracts on conditions like Essential Thrombocythemia. You can view a list of Anna Angona's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Essential ThrombocythemiaMs. Angona isElite. Learn about Essential Thrombocythemia.
- Polycythemia VeraMs. Angona isElite. Learn about Polycythemia Vera.
- Distinguished
- MyelofibrosisMs. Angona isDistinguished. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Ms. Angona isDistinguished. Learn about Myeloproliferative Neoplasms (MPN).
- Advanced
- Blood ClotsMs. Angona isAdvanced. Learn about Blood Clots.
- Chronic Myelogenous Leukemia (CML)
- LeukemiaMs. Angona isAdvanced. Learn about Leukemia.
- VertebroplastyMs. Angona isAdvanced. Learn about Vertebroplasty.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Angona isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Myelomonocytic Leukemia (CMML)Ms. Angona isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- COVID-19Ms. Angona isExperienced. Learn about COVID-19.
- Follicular LymphomaMs. Angona isExperienced. Learn about Follicular Lymphoma.
- Myelodysplastic Syndrome (MDS)Ms. Angona isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaMs. Angona isExperienced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Severe Acute Respiratory Syndrome (SARS)
- SplenomegalyMs. Angona isExperienced. Learn about Splenomegaly.